Drug Patents owned by Almatica

1. List of Forfivo Xl drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7674479 ALMATICA Sustained-release bupropion and bupropion/mecamylamine tablets
Jun, 2027

(4 years from now)

Drugs and Companies using BUPROPION HYDROCHLORIDE ingredient

Market Authorisation Date: 10 November, 2011

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of FORFIVO XL before it's patent expiration?
More Information on Dosage

2. List of Gralise drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8333992 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(3 months ago)

US8192756 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(3 months ago)

US8252332 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(3 months ago)

US7731989 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(3 months ago)

US7438927 ALMATICA Methods of treatment using a gastric retained gabapentin dosage
Feb, 2024

(1 year, 20 days from now)

Drugs and Companies using GABAPENTIN ingredient

Market Authorisation Date: 28 January, 2011

Treatment: Treatment with gabapentin, including treatment of neuropathic pain, including neuropathic pain associated with postherpetic neuralgia

Dosage: TABLET;ORAL

How can I launch a generic of GRALISE before it's patent expiration?
More Information on Dosage

3. List of Loreev Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8999393 ALMATICA Sustained release formulations of lorazepam
Jan, 2034

(10 years from now)

Drugs and Companies using LORAZEPAM ingredient

Market Authorisation Date: 27 August, 2021

Treatment: Once daily treatment of anxiety disorder in adults

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

4. List of Venlafaxine Besylate drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6717015 ALMATICA Venlafaxine besylate
Mar, 2023

(a month from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7776358 ALMATICA Extended release venlafaxine besylate tablets
May, 2028

(5 years from now)

Drugs and Companies using VENLAFAXINE BESYLATE ingredient

Market Authorisation Date: 29 June, 2022

Treatment: Treatment of depression and generalized anxiety disorder

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in